RA CAPITAL MANAGEMENT, L.P. purchased 1.1% of their position (67.67K shares) of HEMAB THERAPEUTICS HOLDINGS, INC. on the open market
Open‑market purchase worth $1.69M — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 6/17/2026ACC: 0001231919-26-000665
Director10% Owner
Since Apr 2026
+67.67K
Net shares
Net buyer
$1.69M
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
67.67K acquired
Non-Derivative Transactions2
Common Stock
Indirect
Shares
+6.15K
Price / share
$24.89
Trade value
$152.97K
% of position
0.1%
6/15/2026
6.38M→6.38M
Common Stock
Indirect
Shares
+61.52K
Price / share
$24.98
Trade value
$1.54M
% of position
1.0%
6/16/2026
6.38M→6.44M
Total
Net shares
+67.67K
Net value
$1.69M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/15/2026 | P · Purchase | +6.15K | $24.89 | $152.97K | 0.1% | 6.38M | 6.38M |
| Common Stock Indirect | 6/16/2026 | P · Purchase | +61.52K | $24.98 | $1.54M | 1.0% | 6.38M | 6.44M |
| Total | +67.67K | $1.69M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned1.01M
Common Stock
IndirectShares owned354.94K
Total
1.36M indirect1.36M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.01M | Indirect |
| Common Stock | 354.94K | Indirect |
| Total | 1.36M | 1.36M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported